Despite the progress of its management, COVID-19 maintains an ominous condition which
constitutes a threat, especially for the susceptible population. The cardiac injury occurs in …

Background: Myocarditis, diagnosed by symptoms and troponin elevation, has been well-
described with COVID-19 infection, as well as shortly after COVID-19 vaccination. The …

Background: Remdesivir (RDV) is the main antiviral for the treatment of moderate to severe
forms of Coronavirus disease 2019 (COVID-19). Several studies revealed a shortening time …

Although COVID-19 is a disease consisting of mostly upper and lower respiratory symptoms,
a subset of patients develop cardiac sequelae including myocarditis and pericarditis. For …

Infectious diseases are a cause of major concern in this twenty-first century. There have
been reports of various outbreaks like severe acute respiratory syndrome (SARS) in 2003 …

One of the severe complications of the severe acute respiratory syndrome coronavirus 2
(SARS‐CoV‐2) infection is myocarditis. However, the characteristics of fulminant myocarditis …

Background: Despite the significant research and development of COVID-19 diagnostic and
therapeutic approaches, the virus still poses a concern, particularly to groups that are …

Myocarditis is described as damage to the heart muscle, which causes inflammation of
myocyte. The etiology consists of infectious and non-infectious diseases. The prevalence of …